The purpose of this study is to report the case of an HIV+ patient with unilateral rifabutin induced intermediate uveitis after 4 months of treatment with low dose rifabutin (150 mg daily) in combination with ritonavir and fluconazole. The uveitis resolved after drug discontinuance and the use ...
36. DMSO and NMP are polar solvents. The addition of Kolliphor®HS 15, an amphiphilic nonionic surfactant formerly known as Solutol HS 15, to DMSO dramatically increased RFB solubility (Fig.2a). The highest RFB solubility, 564 ± 7 mg RFB per mL of ...
Rifabutin at 150 mg/d showed the best risk-to-benefit ratio, in that this group had the highest proportion of patients completing treatment, the highest bacteriological conversion rates and the lowest incidence of adverse events.L.J. Gonzalez-Montaner and S. Natal and P. Yongchaiyud and P. ...
Patients were equally randomized to receive 300 mg of rifabutin every 7 days (group 1) or 150 mg of rifabutin every 3 days (group 2) for 8 weeks. Blood samples were collected over the dosing intervals of the protease inhibitors at baseline (period 1) and of the 3 drugs after 4 weeks ...
After obtaining informed consent, patients received eradication therapy with vonoprazan (20mg), amoxicillin (750mg), and rifabutin (150mg) twice daily for 10days. Eradication was confirmed by a negative H pylori stool antigen or urea breath test at least 8weeks after the end of therapy.#...
showed that the 29% of patients in the 14-day and the 8.3% in the 10-day arm stopped the treatment due to adverse events.1 In our experience,10 the combination of a tetracycline (minocycline 100mg b.i.d) with rifabutin at low dose (150mg b.i.d) given for 10 days allowed a ...
Method: It was found that 99mTc-RFN prepared by mixing 2 mg of RFN, 2.5 mCi sodium pertechnetate, 150 μg stannous chloride at pH 5.4 gave highest yield after 30 minutes and was intact above 90 % after 240min at room temperature in saline. Result: The 99mTc-RFN showed a stable ...